XTX Topco Ltd lessened its stake in Centene Co. (NYSE:CNC - Free Report) by 66.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,689 shares of the company's stock after selling 9,222 shares during the quarter. XTX Topco Ltd's holdings in Centene were worth $284,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently modified their holdings of the company. Virtu Financial LLC bought a new position in Centene in the 3rd quarter valued at $844,000. Wilmington Savings Fund Society FSB acquired a new position in shares of Centene during the third quarter valued at $211,000. Tidal Investments LLC increased its position in Centene by 21.8% in the third quarter. Tidal Investments LLC now owns 42,117 shares of the company's stock worth $3,171,000 after purchasing an additional 7,549 shares during the period. B. Riley Wealth Advisors Inc. raised its holdings in Centene by 32.4% during the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 4,152 shares of the company's stock worth $307,000 after purchasing an additional 1,016 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its position in Centene by 3.7% during the 3rd quarter. Principal Financial Group Inc. now owns 621,664 shares of the company's stock valued at $46,799,000 after purchasing an additional 22,233 shares during the period. 93.63% of the stock is owned by institutional investors.
Analysts Set New Price Targets
CNC has been the subject of several analyst reports. StockNews.com cut shares of Centene from a "strong-buy" rating to a "buy" rating in a research report on Monday. Barclays dropped their target price on shares of Centene from $93.00 to $84.00 and set an "overweight" rating for the company in a research report on Monday. Robert W. Baird reduced their price target on Centene from $71.00 to $69.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 15th. Argus downgraded Centene from a "buy" rating to a "hold" rating in a report on Thursday, February 6th. Finally, Wells Fargo & Company decreased their target price on Centene from $76.00 to $72.00 and set an "overweight" rating for the company in a research report on Friday, February 14th. Seven research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $79.77.
Check Out Our Latest Analysis on Centene
Centene Stock Down 0.4 %
CNC stock traded down $0.25 during trading hours on Thursday, reaching $59.60. 1,507,510 shares of the stock were exchanged, compared to its average volume of 4,745,996. The firm's 50-day moving average is $60.19 and its 200-day moving average is $60.71. Centene Co. has a 12 month low of $55.03 and a 12 month high of $80.59. The company has a market cap of $29.66 billion, a price-to-earnings ratio of 9.56, a PEG ratio of 0.80 and a beta of 0.53. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10.
Centene (NYSE:CNC - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $2.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.52 by $0.38. Centene had a net margin of 2.03% and a return on equity of 13.85%. The company had revenue of $46.62 billion for the quarter, compared to the consensus estimate of $43.16 billion. During the same period last year, the company earned $2.26 earnings per share. The firm's revenue was up 15.4% compared to the same quarter last year. On average, equities research analysts expect that Centene Co. will post 6.86 earnings per share for the current year.
About Centene
(
Free Report)
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Articles

Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.